GG 367 (Benazepril hydrochloride and hydrochlorothiazide 20 mg / 25 mg)

Pill imprint GG 367 has been identified as Benazepril hydrochloride and hydrochlorothiazide 20 mg / 25 mg.

Benazepril is used in the treatment of high blood pressure; diabetic kidney disease; left ventricular dysfunction; heart failure and belongs to the drug class angiotensin converting enzyme inhibitors. There is positive evidence of human fetal risk during pregnancy. Benazepril 20 mg / 25 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for GG 367

Benazepril hydrochloride and hydrochlorothiazide 20 mg / 25 mg GG 367
Benazepril hydrochloride and hydrochlorothiazide
Imprint:
GG 367
Strength:
20 mg / 25 mg
Color:
Red
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Angiotensin converting enzyme inhibitors
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Sandoz Pharmaceuticals Inc.
National Drug Code (NDC):
00781-5134
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
33358-0050 CorePharma, LLC (repackager)

Note: Inactive ingredients may vary.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web4)